Published on: November 13, 2020 at 10:30PM
Condition: New-onset type1 Diabetes
Interventions: Drug: Ladarixin; Drug: Placebo
Sponsor: Dompé Farmaceutici S.p.A
Not yet recruiting
https://ift.tt/36wU0XJ
Friday, 13 November 2020
New diabetes clinical trial: A Phase 3 Randomized, Controlled Study of Oral Ladarixin in New-onset Type 1 Diabetes and a Low Residual β-cell Function
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Nothing happens without a Reason
Make Something out of it.